{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:46:00Z","timestamp":1792089960630,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The percentage of cases with fever of unknown origin after hematopoietic cell transplantation (HCT) is high. An often overlooked clinical infection in HCT recipients may be chronic inflammation from the oral cavity. Therefore, the aim of the present study was to assess fever in the pre-engraftment phase after HCT and to examine the relationship between oral foci of infection before and in the first weeks after HCT and fever.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adult patients, scheduled for autologous or allogeneic HCT, were included in this prospective, observational multicenter cohort study. Oral health was determined pre-HCT. Following HCT conditioning, fever was registered daily; and oral mucositis and other oral side effects were registered three times weekly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Data from 186 patients were available. The mean age was 53.0\u00a0years (\u00b1\u200912.9), and 55.4% were male. The most common malignancies were multiple myeloma, acute myeloid leukemia, and lymphoma. In total, 69.4% of the patients developed fever and 43.1% had an oral ulcerative lesion. After correction for age, site, conditioning regimen, diarrhea, vomiting, and duration of leukopenia, oral ulceration size remained significantly associated with fever, especially when fever was defined as\u2009\u2265\u200938.5\u00b0C. Pre-HCT chronic dental and oral conditions showed no association with post-HCT fever.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Fever was common during the pre-engraftment phase after HCT and significantly associated with the extent of oral ulcerations. In contrast, pre-HCT dental and oral conditions showed no association with post-HCT fever, highlighting the specific role of mucosal injury in febrile episodes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-11267-9","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:23:28Z","timestamp":1790925808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between oral ulcerative lesions, oral infections, and fever during the pre-engraftment phase after hematopoietic cell transplantation: results from the Orastem study"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1291-2798","authenticated-orcid":false,"given":"A. M. G. A.","family":"Laheij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1500-8390","authenticated-orcid":false,"given":"J. E.","family":"Raber-Durlacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3088-1550","authenticated-orcid":false,"given":"B.","family":"Hass\u00e9us","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3036-7554","authenticated-orcid":false,"given":"M. C.","family":"Huysmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4522-3705","authenticated-orcid":false,"given":"S. J. M.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8276-0510","authenticated-orcid":false,"given":"K. Garming","family":"Legert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6658-3865","authenticated-orcid":false,"given":"S.","family":"Isom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. M.","family":"Kline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5113-0249","authenticated-orcid":false,"given":"M. D.","family":"Hazenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8196-8811","authenticated-orcid":false,"given":"F. R.","family":"Rozema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0638-4335","authenticated-orcid":false,"given":"M. T.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5509-4954","authenticated-orcid":false,"given":"I.","family":"von B\u00fcltzingsl\u00f6wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1801-2072","authenticated-orcid":false,"given":"N. M. A.","family":"Blijlevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"issue":"4","key":"11267_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/qco.0000000000000940","volume":"36","author":"Z Shahid","year":"2023","unstructured":"Shahid Z, Epstein DJ (2023) Noninfectious causes of fever in hematologic malignancies. Are antibiotics still indicated? Curr Opin Infect Dis 36(4):209\u2013217. https:\/\/doi.org\/10.1097\/qco.0000000000000940","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"11267_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14236","volume":"26","author":"EJ Stohs","year":"2024","unstructured":"Stohs EJ, Abbas A, Freifeld A (2024) Approach to febrile neutropenia in patients undergoing treatments for hematologic malignancies. Transpl Infect Dis 26(2):e14236. https:\/\/doi.org\/10.1111\/tid.14236","journal-title":"Transpl Infect Dis"},{"issue":"11","key":"11267_CR3","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1038\/s41409-019-0522-4","volume":"54","author":"MM Solh","year":"2019","unstructured":"Solh MM, Dickhaus E, Solomon SR, Morris LE, Zhang X, Holland HK et al (2019) Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomes. Bone Marrow Transplant 54(11):1756\u20131763. https:\/\/doi.org\/10.1038\/s41409-019-0522-4","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"11267_CR4","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1200\/jco.2001.19.8.2201","volume":"19","author":"ST Sonis","year":"2001","unstructured":"Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J et al (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19(8):2201\u20132205. https:\/\/doi.org\/10.1200\/jco.2001.19.8.2201","journal-title":"J Clin Oncol"},{"key":"11267_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11020312","author":"D Carc\u00f2","year":"2022","unstructured":"Carc\u00f2 D, Markovic U, Castorina P, Iachelli V, Pace T, Guardo P et al (2022) C-reactive protein monitoring and clinical presentation of fever as predictive factors of prolonged febrile neutropenia and blood culture positivity after autologous hematopoietic stem cell transplantation-single-center real-life experience. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11020312","journal-title":"J Clin Med"},{"issue":"14","key":"11267_CR6","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1200\/jco.2017.77.6211","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK et al (2018) Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. J Clin Oncol 36(14):1443\u20131453. https:\/\/doi.org\/10.1200\/jco.2017.77.6211","journal-title":"J Clin Oncol"},{"issue":"suppl 5","key":"11267_CR7","doi-asserted-by":"publisher","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","volume":"27","author":"J Klastersky","year":"2016","unstructured":"Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M et al (2016) Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol 27(suppl 5):v111\u2013v118. https:\/\/doi.org\/10.1093\/annonc\/mdw325","journal-title":"Ann Oncol"},{"issue":"9","key":"11267_CR8","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41409-022-01719-1","volume":"57","author":"CEM de Mooij","year":"2022","unstructured":"de Mooij CEM, van der Velden WJFM, de Haan AFJ, Fazel S, van Groningen LFJ, Blijlevens NMA (2022) Grading bloodstream infection risk using citrulline as a biomarker of intestinal mucositis in patients receiving intensive therapy. Bone Marrow Transpl 57(9):1373\u20131381. https:\/\/doi.org\/10.1038\/s41409-022-01719-1","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"11267_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/tid.12195","volume":"16","author":"AHE Herbers","year":"2014","unstructured":"Herbers AHE, de Haan AFJ, van der Velden WJFM, Donnelly JP, Blijlevens NMA (2014) Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients. Transpl Infect Dis 16(2):279\u2013285. https:\/\/doi.org\/10.1111\/tid.12195","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"11267_CR10","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2010","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA et al (2010) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):e56-93. https:\/\/doi.org\/10.1093\/cid\/cir073","journal-title":"Clin Infect Dis"},{"issue":"1","key":"11267_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s15010-013-0525-9","volume":"42","author":"L Nesher","year":"2014","unstructured":"Nesher L, Rolston KV (2014) The current spectrum of infection in cancer patients with chemotherapy related neutropenia. Infection 42(1):5\u201313. https:\/\/doi.org\/10.1007\/s15010-013-0525-9","journal-title":"Infection"},{"issue":"12","key":"11267_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-10087-7","volume":"33","author":"N Yamaji","year":"2025","unstructured":"Yamaji N, Morita K, Ono S, Ishimaru M, Aso S, Yotani N et al (2025) Association between oral management and complications after hematopoietic stem cell transplantation. Support Care Cancer 33(12):1141. https:\/\/doi.org\/10.1007\/s00520-025-10087-7","journal-title":"Support Care Cancer"},{"issue":"1","key":"11267_CR13","doi-asserted-by":"publisher","first-page":"16929","DOI":"10.1038\/s41598-019-53073-w","volume":"9","author":"A Laheij","year":"2019","unstructured":"Laheij A, Raber-Durlacher JE, Koppelmans RGA, Huysmans M, Potting C, van Leeuwen SJM et al (2019) Microbial changes in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients. Sci Rep 9(1):16929. https:\/\/doi.org\/10.1038\/s41598-019-53073-w","journal-title":"Sci Rep"},{"issue":"4","key":"11267_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10040734","volume":"10","author":"AMGA Laheij","year":"2022","unstructured":"Laheij AMGA, Rozema FR, Brennan MT, von B\u00fcltzingsl\u00f6wen I, van Leeuwen SJM, Potting C et al (2022) Long-term analysis of resilience of the oral microbiome in allogeneic stem cell transplant recipients. Microorganisms 10(4):734","journal-title":"Microorganisms"},{"issue":"9","key":"11267_CR15","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/bjc.2016.60","volume":"114","author":"JM Schuurhuis","year":"2016","unstructured":"Schuurhuis JM, Span LF, Stokman MA, van Winkelhoff AJ, Vissink A, Spijkervet FK (2016) Effect of leaving chronic oral foci untreated on infectious complications during intensive chemotherapy. Br J Cancer 114(9):972\u2013978. https:\/\/doi.org\/10.1038\/bjc.2016.60","journal-title":"Br J Cancer"},{"issue":"4","key":"11267_CR16","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s00520-020-05733-1","volume":"29","author":"HJ Hansen","year":"2021","unstructured":"Hansen HJ, Estilo C, Owosho A, Solano AK, Randazzo J, Huryn J et al (2021) Dental status and risk of odontogenic complication in patients undergoing hematopoietic stem cell transplant. Support Care Cancer 29(4):2231\u20132238. https:\/\/doi.org\/10.1007\/s00520-020-05733-1","journal-title":"Support Care Cancer"},{"issue":"1","key":"11267_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/odi.13329","volume":"27","author":"FKL Spijkervet","year":"2021","unstructured":"Spijkervet FKL, Schuurhuis JM, Stokman MA, Witjes MJH, Vissink A (2021) Should oral foci of infection be removed before the onset of radiotherapy or chemotherapy? Oral Dis 27(1):7\u201313. https:\/\/doi.org\/10.1111\/odi.13329","journal-title":"Oral Dis"},{"issue":"4","key":"11267_CR18","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.2196\/resprot.8982","volume":"7","author":"MT Brennan","year":"2018","unstructured":"Brennan MT, Hass\u00e9us B, Hovan AJ, Raber-Durlacher JE, Blijlevens NM, Huysmans MC et al (2018) Impact of oral side effects from conditioning therapy before hematopoietic stem cell transplantation: protocol for a multicenter study. JMIR Res Protoc 7(4):e103. https:\/\/doi.org\/10.2196\/resprot.8982","journal-title":"JMIR Res Protoc"},{"issue":"5","key":"11267_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285615","volume":"18","author":"K Skallsj\u00f6","year":"2023","unstructured":"Skallsj\u00f6 K, von B\u00fcltzingsl\u00f6wen I, Hass\u00e9us B, Johansson JE, \u00d6hman J, Raber-Durlacher JE et al (2023) Oral health in patients scheduled for hematopoietic stem cell transplantation in the Orastem study. PLoS One 18(5):e0285615. https:\/\/doi.org\/10.1371\/journal.pone.0285615","journal-title":"PLoS ONE"},{"issue":"4","key":"11267_CR20","doi-asserted-by":"publisher","first-page":"446.e1","DOI":"10.1016\/j.jtct.2024.01.067","volume":"30","author":"MS Bulthuis","year":"2024","unstructured":"Bulthuis MS, van Leeuwen SJM, Thomas RZ, van Gennip LLA, Whiteside HM, Isom S et al (2024) Subjective oral dryness following hematopoietic cell transplantation: a report from the Orastem study. Transplant Cell Ther 30(4):446.e1. https:\/\/doi.org\/10.1016\/j.jtct.2024.01.067","journal-title":"Transplant Cell Ther"},{"key":"11267_CR21","unstructured":"World Health Organization (1979) WHO handbook for reporting results of cancer treatment.\u00a0World Health Organization,\u00a0Geneva"},{"issue":"10","key":"11267_CR22","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1002\/(sici)1097-0142(19990515)85:10<2103::aid-cncr2>3.0.co;2-0","volume":"85","author":"ST Sonis","year":"1999","unstructured":"Sonis ST, Eilers JP, Epstein JB, LeVeque FG, Liggett WH Jr, Mulagha MT et al (1999) Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group Cancer 85(10):2103\u20132113. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19990515)85:10%3c2103::aid-cncr2%3e3.0.co;2-0","journal-title":"Mucositis Study Group Cancer"},{"issue":"4","key":"11267_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.bmt.1705250","volume":"37","author":"PJ Stiff","year":"2006","unstructured":"Stiff PJ, Erder H, Bensinger WI, Emmanouilides C, Gentile T, Isitt J et al (2006) Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT). Bone Marrow Transplant 37(4):393\u2013401. https:\/\/doi.org\/10.1038\/sj.bmt.1705250","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"11267_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-07654-1","volume":"31","author":"PS Satheeshkumar","year":"2023","unstructured":"Satheeshkumar PS, Blijlevens N, Sonis ST (2023) Application of big data analyses to compare the impact of oral and gastrointestinal mucositis on risks and outcomes of febrile neutropenia and septicemia among patients hospitalized for the treatment of leukemia or multiple myeloma. Support Care Cancer 31(3):199. https:\/\/doi.org\/10.1007\/s00520-023-07654-1","journal-title":"Support Care Cancer"},{"issue":"1","key":"11267_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41375-023-02077-7","volume":"38","author":"S Weischendorff","year":"2024","unstructured":"Weischendorff S, Rathe M, Petersen MJ, Weimann A, Enevold C, Nielsen CH et al (2024) Markers of intestinal mucositis to predict blood stream infections at the onset of fever during treatment for childhood acute leukemia. Leukemia 38(1):14\u201320. https:\/\/doi.org\/10.1038\/s41375-023-02077-7","journal-title":"Leukemia"},{"issue":"5","key":"11267_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.6004\/jnccn.2004.0033","volume":"2","author":"AG Freifeld","year":"2004","unstructured":"Freifeld AG, Baden LR, Brown AE, Elting LS, Gelfand M, Greene JN et al (2004) Fever and neutropenia clinical practice guidelines. J Natl Compr Canc Netw 2(5):390\u2013432. https:\/\/doi.org\/10.6004\/jnccn.2004.0033","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"11267_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098274","volume":"24","author":"JS Bruno","year":"2023","unstructured":"Bruno JS, Al-Qadami GH, Laheij AMGA, Bossi P, Fregnani ER, Wardill HR (2023) From pathogenesis to intervention: the importance of the microbiome in oral mucositis. Int J Mol Sci 24(9):8274","journal-title":"Int J Mol Sci"},{"issue":"4","key":"11267_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/bjh.13113","volume":"167","author":"WJ van der Velden","year":"2014","unstructured":"van der Velden WJ, Herbers AH, Netea MG, Blijlevens NM (2014) Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis. Br J Haematol 167(4):441\u2013452. https:\/\/doi.org\/10.1111\/bjh.13113","journal-title":"Br J Haematol"},{"issue":"6","key":"11267_CR29","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s00520-002-0346-3","volume":"10","author":"JE Raber-Durlacher","year":"2002","unstructured":"Raber-Durlacher JE, Epstein JB, Raber J, van Dissel JT, van Winkelhoff AJ, Guiot HF et al (2002) Periodontal infection in cancer patients treated with high-dose chemotherapy. Support Care Cancer 10(6):466\u2013473. https:\/\/doi.org\/10.1007\/s00520-002-0346-3","journal-title":"Support Care Cancer"},{"issue":"8","key":"11267_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/s1368-8375(01)00025-2","volume":"37","author":"JB Epstein","year":"2001","unstructured":"Epstein JB, Stevenson-Moore P (2001) Periodontal disease and periodontal management in patients with cancer. Oral Oncol 37(8):613\u2013619. https:\/\/doi.org\/10.1016\/s1368-8375(01)00025-2","journal-title":"Oral Oncol"},{"issue":"12","key":"11267_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225099","volume":"14","author":"M Mauramo","year":"2019","unstructured":"Mauramo M, Grolimund P, Egli A, Passweg J, Halter J, Waltimo T (2019) Dissociations of oral foci of infections with infectious complications and survival after haematopoietic stem cell transplantation. PLoS ONE 14(12):e0225099. https:\/\/doi.org\/10.1371\/journal.pone.0225099","journal-title":"PLoS ONE"},{"key":"11267_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2022.940044","volume":"3","author":"J Zecha","year":"2022","unstructured":"Zecha J, Raber-Durlacher JE, Laheij A, Westermann AM, de Lange J, Smeele LE (2022) The potential contribution of dental foci and oral mucositis to febrile neutropenia in patients treated with myelosuppressive chemotherapy for solid tumors and lymphoma. Front Oral Health 3:940044. https:\/\/doi.org\/10.3389\/froh.2022.940044","journal-title":"Front Oral Health"},{"issue":"12","key":"11267_CR33","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s00520-024-08991-5","volume":"32","author":"LLA van Gennip","year":"2024","unstructured":"van Gennip LLA, Thomas RZ, Bulthuis MS, Hannink G, Bronkhorst EM, Blijlevens NMA et al (2024) Oral foci of infection and their relationship with hospital stay after haematopoietic cell transplantation. Support Care Cancer 32(12):816. https:\/\/doi.org\/10.1007\/s00520-024-08991-5","journal-title":"Support Care Cancer"},{"issue":"19","key":"11267_CR34","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1002\/cncr.33100","volume":"126","author":"S Elad","year":"2020","unstructured":"Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM et al (2020) MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 126(19):4423\u20134431. https:\/\/doi.org\/10.1002\/cncr.33100","journal-title":"Cancer"},{"issue":"5","key":"11267_CR35","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1007\/s00520-019-05217-x","volume":"28","author":"MEP Correa","year":"2020","unstructured":"Correa MEP, Cheng KKF, Chiang K, Kandwal A, Loprinzi CL, Mori T et al (2020) Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 28(5):2449\u20132456. https:\/\/doi.org\/10.1007\/s00520-019-05217-x","journal-title":"Support Care Cancer"},{"issue":"11","key":"11267_CR36","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1007\/s00520-013-1871-y","volume":"21","author":"DP Saunders","year":"2013","unstructured":"Saunders DP, Epstein JB, Elad S, Allemano J, Bossi P, van de Wetering MD et al (2013) Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer 21(11):3191\u20133207. https:\/\/doi.org\/10.1007\/s00520-013-1871-y","journal-title":"Support Care Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11267-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11267-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11267-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:47:47Z","timestamp":1792086467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11267-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11267"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11267-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"24 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JRD is a Deputy Associate Editor of this journal.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1044"}}